Physician profile
Basma Fallah
NPI 1841486248
$1,303.16
in general payments reported to CMS, 2019-2025
9 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $106 · 2021: $355 · 2022: $219 · 2023: $130 · 2024: $49.44 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.92 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $750.46 | 2019-2025 | Invisalign, Itero, Invisalign Touch Up |
| American Orthodontics Corporation | $162.43 | 2019-2025 | LP and Ifit Tubes, Master Series, Radiance |
| Envista Holdings Corporation | $138.86 | 2025 | Spark |
| Ortho Organizers, INC. | $79.91 | 2022-2023 | Carriere, Reveal Aligners |
| Ormco Corporation | $76.76 | 2019-2023 | Red, White and Blue Retainer |
| Straumann USA LLC | $33.50 | 2024 | |
| Forestadent USA, INC. | $32.23 | 2019 | |
| 3m Company | $16.20 | 2020 | |
| Nobel Biocare USA | $12.81 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basma Fallah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.